Zai Lab Announced That Data From Phase 1 Study Of ZL-1310 Will Be Presented During A Plenary Session At The EORTC-NCI-AACR Symposium, The Preliminary Results From The Ongoing Trial Will Address The Potential Of ZL-1310 For Small Cell Lung Cancer
Zai Lab Announced That Data From Phase 1 Study Of ZL-1310 Will Be Presented During A Plenary Session At The EORTC-NCI-AACR Symposium, The Preliminary Results From The Ongoing Trial Will Address The Potential Of ZL-1310 For Small Cell Lung Cancer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated